FDA shall
examine the number of firms reporting changes over the next several
years to determine if this figure requires updating.
Inventory as of this Action
Requested
Previously Approved
12/31/2006
12/31/2006
12/31/2003
75
0
50
129
0
50
0
0
0
This guidance from the Food and Drug
Administration provides instructions on the process for firms to
seek inclusion on the list of U.S. dariy firms that export or
intend to export to Chile. Under this guidance, U.S. firms that
want to be placed on the list will send information to FDA (e.g.,
name and address of the firm and the manufacturing plant, list of
products presently shipped and expected to be shipped in the
future, identities of agencies that inspect the plant, plant number
and copy of last inspection).
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.